Physician profile
David C Weeks
NPI 1548285968
$1,026.93
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $48.11 · 2021: $120 · 2022: $501.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $400.00 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.02 | 2020-2022 | |
| Pfizer INC. | $71.45 | 2019-2022 | |
| Abbvie INC. | $64.33 | 2022 | |
| Coloplast Corp | $59.40 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $58.65 | 2019 | |
| Boston Scientific Corporation | $53.61 | 2019 | |
| Allergan, INC. | $49.94 | 2019-2022 | |
| Dendreon Pharmaceuticals LLC | $32.10 | 2019 | |
| Teleflex LLC | $27.82 | 2022 | |
| Progenics Pharmaceuticals, INC. | $25.68 | 2022 | |
| Myovant Sciences INC. | $21.74 | 2022 | |
| Urovant Sciences INC | $20.30 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $18.14 | 2019 | |
| Amgen INC. | $17.53 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $13.21 | 2022 | |
| Urogen Pharma, INC. | $12.01 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.